June 5, 2018 07:18 AM EDTUpdated 09:12 AM
Financing

Hours af­ter fil­ing $150M IPO, Tri­ci­da shares pos­i­tive PhI­II tri­al re­sults on CKD drug

Brittany Meiling

South San Fran­cis­co drug­mak­er Tri­ci­da sig­naled plans late Mon­day to raise $150 mil­lion in an IPO, stock­pil­ing cash to fu­el the com­pa­ny’s NDA fil­ing and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times